| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| USD | 550.000 | 2 | Mar-24 | Sr. Secured | - | A+ | A | Fixed | Tsy | T+115 a | T+100 | 100 | 2.51% | 12 | 100.00000 |
| USD | 500.000 | 5 | Mar-27 | Sr. Secured | - | A+ | A | Fixed | Tsy | T+160 a | T+145 | 145 | 3.21% | 15 | 100.00000 |
Tranche Comments
2 yr: Registration: 144A/Reg S; Comments: US$550m 2.514% cpn 2yr FXD at 100.00, yld 2.514%. T+100bp;
5 yr: Registration: 144A/Reg S; Comments: US$500m 3.205% cpn 5yr FXD at 100.00, yld 3.205%. T+145bp;
Deal Comments
FA-Backed. Joint Bookrunners: DEU, MOS; 2yr: BAM, RBC; 5yr: BNP, GSC
Use of Proceeds
To purchase funding agreements from Athene Life Co
AllReportsSurveillanceOther